In this video, Anat Loewenstein, MD, MHA, of Tel Aviv Medical Center, Israel, highlights information presented at the American Society of Retina Specialists annual meeting on the management of age-related macular degeneration.
“In the AMD space, we are fortunate to see new and more robust data on long-term drugs, including genetic therapies and [tyrosine kinase inhibitors], showing very good results over the long term with significant safety,” Loewenstein said.